Racial Disparities in the Use of MRI and PET Scan Among Medicare Beneficiaries With Prostate Cancer
Rattachement africain : us, at, it, gb. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
BACKGROUND: Despite recent advances in imaging technologies for prostate cancer (PCa) staging, unequal access to new technologies may aggravate racial disparities. We aim to investigate racial disparities in the utilization of Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) scans in a sample of 100% Medicare beneficiaries. METHODS: In this retrospective cross-sectional study, we analyzed 100% Medicare insurance claims from 2018 to 2023. We included male beneficiaries aged 66 and above diagnosed with PCa between January 1, 2019 and December 31, 2023. The primary outcome measure was the receipt of advanced imaging within 1 year after PCa diagnosis. Patient characteristics included race/ethnicity, age, U.S. region, county type, year of diagnosis, comorbidities, dual eligibility for Medicare, and disability status. Chi-squared tests and clustered multivariable regression analyses were conducted to assess differences in the utilization of advanced imaging among patient subgroups. RESULTS: We identified a total of 749,202 Medicare beneficiaries diagnosed with PCa in the study period. The study cohort was 84.0% White, 8.7% Black, 4.1% other, and 3.2% unknown race/ethnicity. Black men were less likely to receive MRI (OR 0.84,95% CI 0.80-0.89, p < 0.0001) and PET scan (OR 0.87,95% CI 0.84-0.91, p < 0.0001) compared to White men. Absolute utilization of MRI for PCa staging remains low, while PET scan utilization increased from 6% in 2019% to 21% in 2023. CONCLUSIONS: Utilization of advanced imaging in men with newly diagnosed PCa is significantly lower among Black men compared to White men. Improving equal access to new technologies is essential to reducing racial disparities in PCa care.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Racial Disparities in the Use of MRI and PET Scan Among Medicare Beneficiaries With Prostate Cancer
- Date Crossref
- 29/07/2025
- Éditeur
- Wiley
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Brigham and Women's Hospital Center for Surgery and Public Health pays non établi dans la noticeÉtablissement de santé
-
Harvard University pays non établi dans la noticeUniversité ou école supérieure
-
Medical University of Graz Department of Urology pays non établi dans la noticeUniversité ou école supérieure
-
Vienna General Hospital pays non établi dans la noticeÉtablissement de santé
-
IRCCS Humanitas Research Hospital pays non établi dans la noticeÉtablissement de santé
-
Boston University pays non établi dans la noticeUniversité ou école supérieure
-
University College London Department of Urology and Division of Surgery & pays non établi dans la noticeUniversité ou école supérieure
-
Dana-Farber Cancer Institute pays non établi dans la noticeStructure de recherche
-
University of Pittsburgh Medical Center Department of Urology pays non établi dans la noticeÉtablissement de santé
-
General Hospital Medical University Vienna Vienna Austria Department of Urology pays non établi dans la noticeUniversité ou école supérieure
-
Department of Urology Humanitas Research Hospital – IRCCS Milan Italy pays non établi dans la noticeÉtablissement de santé
-
Chobanian and Avedisian School of Medicine pays non établi dans la noticeUniversité ou école supérieure
Center for Surgery and Public Health — Brigham and Women's Hospital, Harvard University et Department of Urology — Medical University of Graz, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.